By Josh White
Date: Thursday 29 Feb 2024
(Sharecast News) - Oncimmune reported revenue of £2.1m in its final results on Thursday, down from £3.8m for the prior extended 15-month period, with revenue from continuing operations totalling £1.2m.
By Josh White
Date: Monday 22 May 2023
(Sharecast News) - Immunodiagnostics specialist Oncimmune announced the sale of its wholly-owned subsidiaries Oncimmune Limited and Oncimmune Europe to the US-based, privately-held Freenome Holdings on Monday.
By Josh White
Date: Friday 17 Feb 2023
(Sharecast News) - Immunodiagnostics specialist Oncimmune announced a collaboration with Siemens Healthineers on Friday, to improve malignancy risk assessment of indeterminate pulmonary nodules (IPNs).
Currency | UK Pounds |
Share Price | 23.50p |
Change Today | -1.00p |
% Change | -4.08 % |
52 Week High | 40.50 |
52 Week Low | 15.10 |
Volume | 4,000 |
Shares Issued | 74.14m |
Market Cap | £17.42m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
11:38 | 2,000 @ 24.38p |
08:00 | 2,000 @ 22.20p |
You are here: research